Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma
Clinical trial NCT05535647 · UNKNOWN
Trial details
- NCT number
- NCT05535647
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-25
- Primary completion
- 2024-09-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.